BU-NOT-SET

CONTACT US
A CDMO’s insight into the pharma M&A landscape
  • Industry trends
Eyes
Insight
Recipharm’s continuous global support throughout the COVID-19 pandemic
  • Industry trends
Eyes
Insight
Is outsourcing the most viable pathway for innovators?
  • Manufacturing
Meeting
Insight
Developing a generic prolonged-release isosorbide-5-mononitrate tablet
  • Drug product
Two lab workers
Case study
Recipharm Wins two 2020 CMO Leadership Awards
  • Industry trends
Eyes
Insight
Recipharm’s global teams support and engage with their local communities in the fight against COVID-19
  • Corporate
Eyes
Insight
Recipharm launches new virtual inspection and audit tool for customers, in light of COVID-19 outbreak
  • Manufacturing
Eyes
Insight
Recipharm 25 years
  • Corporate
24 years
Brochure
API product list
  • Drug substance
white pills
Fact sheet
Report
  • Sustainability
Sustainability Report 2021
Insight
  • Corporate
Treating long-COVID with Erdosteine
Insight
  • Drug product
Three trends driving small molecule API market growth
Fact sheet
  • Drug product
Vaccine manufacturing
Insight
  • Drug product
Solving the challenges during oral solid dosage development
Insight
  • Drug product
mRNA vaccine manufacturing: how to unlock success
Insight
  • Manufacturing
Pharma packaging trends under the spotlight
Insight
  • Drug product
Modified release formulation and manufacture
Webinar
  • Drug product
Aseptic manufacturing – design of lines for filling and lyophilisation